Indivior (LON:INDV) Shares Down 17% – Here’s Why

Shares of Indivior PLC (LON:INDV) dropped 17% during trading on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 720.60 ($9.07). Approximately 2,904,792 shares traded hands during trading, an increase of 294% from the average daily volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.65) price objective on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 17.0 %

The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The company has a market capitalization of £1.13 billion, a price-to-earnings ratio of -597.48, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a 50-day moving average price of GBX 928.06 and a 200-day moving average price of GBX 853.71.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.